Home/Filings/4/0001760173-19-000032
4//SEC Filing

Louw Johannes Wynand 4

Accession 0001760173-19-000032

CIK 0001760173other

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 12:17 PM ET

Size

26.7 KB

Accession

0001760173-19-000032

Insider Transaction Report

Form 4
Period: 2019-03-08
Louw Johannes Wynand
Vice President Finance
Transactions
  • Award

    Option to purchase Common Stock

    2019-03-08$4.02/sh+6,000$24,1206,000 total
    Exercise: $4.02From: 2019-03-08Exp: 2022-02-09Common Stock (6,000 underlying)
  • Award

    Option to purchase Common Stock

    2019-03-08$2.69/sh+2,000$5,3802,000 total
    Exercise: $2.69From: 2019-03-08Exp: 2021-02-28Common Stock (2,000 underlying)
  • Award

    Option to purchase Common Stock

    2019-03-08$3.78/sh+20,000$75,60020,000 total
    Exercise: $3.78From: 2019-03-08Exp: 2024-02-25Common Stock (20,000 underlying)
  • Award

    Option to purchase Common Stock

    2019-03-08$5.23/sh+20,000$104,60020,000 total
    Exercise: $5.23Exp: 2025-02-17Common Stock (20,000 underlying)
  • Award

    Option to purchase Common Stock

    2019-03-08$4.60/sh+26,432$121,58726,432 total
    Exercise: $4.60Exp: 2027-05-03Common Stock (26,432 underlying)
  • Award

    Common Stock

    2019-03-08+39,35939,359 total
  • Award

    Option to purchase Common Stock

    2019-03-08$4.26/sh+12,376$52,72212,376 total
    Exercise: $4.26Exp: 2028-11-29Common Stock (12,376 underlying)
  • Award

    Option to purchase Common Stock

    2019-03-08$4.25/sh+20,500$87,12520,500 total
    Exercise: $4.25Exp: 2028-02-29Common Stock (20,500 underlying)
  • Award

    Option to purchase Common Stock

    2019-03-08$3.60/sh+15,000$54,00015,000 total
    Exercise: $3.60From: 2019-03-08Exp: 2023-02-25Common Stock (15,000 underlying)
  • Award

    Option to purchase Common Stock

    2019-03-08$3.31/sh+19,355$64,06519,355 total
    Exercise: $3.31Exp: 2026-02-24Common Stock (19,355 underlying)
Footnotes (8)
  • [F1]On March 8, 2019, pursuant to the Master Transaction Agreement, by and among the Issuer, RTI Surgical, Inc., a Delaware corporation ("Old RTI"), PS Spine Holdco, LLC, a Delaware limited liability company (the "Member"), and Bears Merger Sub, Inc., a Delaware corporation (the "Merger Sub"): (a) the Merger Sub merged with and into Old RTI, with Old RTI surviving as a wholly-owned subsidiary of the Issuer (the "Merger"); (b) the Member contributed all of the issued and outstanding membership interests of Paradigm Spine, LLC, a Delaware limited liability company and wholly owned subsidiary of the Member, to the Issuer; and (c) the Issuer was renamed "RTI Surgical Holdings, Inc."
  • [F2]Pursuant to the Master Transaction Agreement, at the effective time of the Merger: (a) each issued and outstanding share of common stock of Old RTI converted automatically into one share of the Issuer's common stock; (b) each issued and outstanding share of Series A Convertible Preferred Stock of Old RTI converted automatically into one share of the Issuer's Series A Convertible Preferred Stock; and (c) each stock option and restricted stock award granted by Old RTI converted into a stock option or restricted stock award, as applicable, of the Issuer with respect to an equivalent number of shares of the Issuer's common stock on the same terms and conditions as were applicable prior to the Closing. This report reflects the beneficial ownership of the reporting person at the time of the consummation of the Merger and does not include the securities of the Issuer acquired by the reporting person upon the consummation of the Merger.
  • [F3]Total includes 29,909 shares of restricted stock that will vest on; 4,348 shares will vest on both 5/03/2019 and 5/03/2020, 3,100 shares will vest on both 2/29/2020 and 2/28/2021, 1,957 shares will vest on 11/29/2019 and 1,956 shares will vest on both 11/29/2020 and 11/29/2021, 3,048 shares will vest on 2/26/2020, 2/26/2021 and 2/26/2022.
  • [F4]Total includes 16,000 exercisable options and 4,000 that will become exercisable on 2/17/2020.
  • [F5]Total includes 11,613 exercisable options and 3,871 will become exercisable on both 2/24/2020 and 2/24/2021.
  • [F6]Total includes 5,287 exercisable options and 5,287 will become exercisable on 5/3/2019 and 5,286 will become exercisable on each 5/03/2020. 05/03/2021 and 05/03/2022.
  • [F7]Total includes 4,100 exercisable options and 4,100 options will become exercisable on each of 2/29/2020, 2/28/2021, 2/28/2022 and 2/28/2023.
  • [F8]This option will become exercisable as to 2,475 shares on each of 11/29/2019, 11/29/2020, 11/29/2021, 11/29/2022 and 2,476 shares on 11/29/2023.

Issuer

RTI Surgical Holdings, Inc.

CIK 0001760173

Entity typeother

Related Parties

1
  • filerCIK 0001692544

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 12:17 PM ET
Size
26.7 KB